| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/05/2009 | US7527961 Production of vaccines |
| 05/05/2009 | US7527960 Recombinant canarypox or fowlpox vector comprising a nucleic acid molecule encoding foot-and-mouth disease virus antigen |
| 05/05/2009 | US7527800 Influenza hemagglutinin and neuraminidase variants |
| 05/05/2009 | CA2173338C Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 04/30/2009 | WO2009054996A2 Systems and methods for viral therapy |
| 04/30/2009 | WO2009053700A1 Modification of nucleic acid-containing biological entities |
| 04/30/2009 | WO2009053604A2 Influenza virus haemagglutinin-specific monoclonal antibodies |
| 04/30/2009 | WO2007148326A3 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders |
| 04/30/2009 | WO2007016275A3 Methods and compositions for detecting bk virus |
| 04/30/2009 | US20090111172 isolated polypeptide is immobilized on an immunosorbent surface of ELISA plate for determining whether a mouse is infected with murine norovirus-1 by determining presence, absence or quantity of antibody against MNV-1 a sample of a mouse |
| 04/30/2009 | US20090111123 Compositions for detecting antibodies to babesia microti and methods of uses thereof |
| 04/30/2009 | US20090111106 Vector System |
| 04/30/2009 | US20090111092 Determination of hepatitis c virus genotype |
| 04/30/2009 | US20090110694 Anti-Inflammatory Proteins and Improved Vaccines |
| 04/30/2009 | US20090110665 Reovirus for the treatment of neoplasia |
| 04/30/2009 | CA2703066A1 Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres |
| 04/30/2009 | CA2700430A1 Influenza virus haemagglutinin-specific monoclonal antibodies |
| 04/29/2009 | EP2053124A2 Recombinant RSV virus expression systems and vaccines |
| 04/29/2009 | EP0835315B1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 04/29/2009 | CN101418286A Artificial pseudotype virus of human immunodeficiency virus I type as well as preparation and application thereof |
| 04/29/2009 | CN100482788C High-yield recombinant influenza B virus strain and its application |
| 04/28/2009 | US7524927 Compositions, method and kits relating to deletion mutations of immunodeficiency virus gp120 hypervariable regions |
| 04/28/2009 | US7524676 Large scale productions of virus antigen |
| 04/28/2009 | US7524650 Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
| 04/28/2009 | US7524508 Contain large deletions; vaccines against dengue virus infection; structural proteins encapsulate said subgenomic replicon |
| 04/28/2009 | US7524506 gM-negative EHV-mutants without heterologous elements |
| 04/28/2009 | CA2191978C Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
| 04/23/2009 | WO2009050390A2 Method for producing flu virus |
| 04/23/2009 | WO2008136852A3 Methods and compositions related to the structure and function of apobec3g |
| 04/23/2009 | WO2005079162A3 Engrafted plants resistant to viral diseases and methods of producing same |
| 04/23/2009 | US20090105279 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV. |
| 04/23/2009 | US20090105151 Amphipathic alpha-helical peptide compositions as antiviral agents |
| 04/23/2009 | US20090105090 Phage Display By Novel Filamentous Bacteriophage |
| 04/23/2009 | US20090104702 Attenuated chimeric flavivirus bearing attenuated Japanese encephalitis virus gene as backbone |
| 04/23/2009 | US20090104682 Construction of novel strains containing minimizing genome by tn5-coupled cre/loxp excision system |
| 04/23/2009 | US20090104228 Influenza Virus Vaccine |
| 04/23/2009 | US20090104225 using recombinant modified vaccinia virus Ankara (MVA) encoding a polypeptide comprising a human prostate-specific antigen (PSA) antigen and another encoding prostatic acid phosphatase (PAP); can induce B- and T-cell responses |
| 04/23/2009 | US20090104224 Modified vaccinia virus ankara for the vaccination of neonates |
| 04/23/2009 | US20090104162 Attenuated reoviruses for selection of cell populations |
| 04/23/2009 | CA2703034A1 Viral modification |
| 04/23/2009 | CA2700288A1 Method for producing flu virus |
| 04/22/2009 | EP2050822A1 Hepatitis C virus replicons and replicon enhanced cells |
| 04/22/2009 | EP2050820A1 Pro-clotting enzyme, and method for detection of endotoxin or (1 3)- -d-glucan using the same |
| 04/22/2009 | EP2049657A1 Filter assembly for a reprocessor |
| 04/22/2009 | EP2049153A1 Attenuated polio viruses |
| 04/22/2009 | EP1057889B1 Enhanced immunogen for inactivated vaccine for infection with japanese encephalitis viruses and process for producing the same |
| 04/22/2009 | EP0882134B1 Methods and compositions for protective and therapeutic genetic immunization |
| 04/22/2009 | CN100480377C Infectious bursal disease virus VP2 gene expressed recombinant newcastle disease LaSota attenuated vaccine strain |
| 04/21/2009 | US7521220 Production of vaccines |
| 04/21/2009 | US7521219 Method of producing baculovirus |
| 04/21/2009 | US7521218 use thereof for spreading living attenuated viruses; culture medium comprising a chicken serum and a culture support comprising inactivated 3T3 cells |
| 04/21/2009 | US7521058 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine |
| 04/16/2009 | WO2008157530A3 Vaccine design methodology |
| 04/16/2009 | WO2008140610A9 Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast |
| 04/16/2009 | WO2007018853A3 Secretion of antibodies without signal peptides from bacteria |
| 04/16/2009 | WO2007002373A3 Use of mutant herpes simplex virus-2 for cancer therapy |
| 04/16/2009 | WO2006105279A3 Defective sindbis viral vectors |
| 04/16/2009 | WO2006093967A3 Compositions and methods for targeting or imaging a tissue in a vertebrate subject |
| 04/16/2009 | WO2005112567A3 Vaginal microbicide |
| 04/16/2009 | US20090099239 Antiviral Compounds and Methods |
| 04/16/2009 | US20090099125 Pan cancer oncolytic vectors and methods of use thereof |
| 04/16/2009 | US20090099096 HIV proteases as therapeutic agents for inhibition and treatment of HIV infection in humans, administered in combination with other classes of HIV therapeutic agents, especially inhibitors of HIV reverse transcriptase |
| 04/16/2009 | US20090098634 Scleroprotein of an adeno associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/16/2009 | US20090098633 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 04/16/2009 | US20090098632 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/16/2009 | US20090098604 host cells; tumor antigens; for treatment, prevention of cancer |
| 04/16/2009 | US20090098530 Cell Line For Producing Coronaviruses |
| 04/16/2009 | US20090098529 Methods for attenuating virus strains for diagnostic and therapeutic uses |
| 04/16/2009 | US20090098161 removal of structural features of HIV that interfere with immune response. In particular, sialic acid is removed to enhance immune recognition and to impair Complement Factor H binding, CD55 and CD59 removal prevent the binding of Complement Factor H; Acquired Immunodeficiency Syndrome |
| 04/16/2009 | US20090098160 sialic acid is removed to enhance immune recognition and to impair Complement Factor H binding; CD55 and CD59 removal prevents the binding of Complement Factor H; Acquired Immunodeficiency Syndrome |
| 04/16/2009 | US20090098159 Cultured feline fetal tissue generated in absence of mammalian polypeptides for use as bioreactor in production of inexpensive feline vaccine |
| 04/16/2009 | US20090098152 Vaccines Containing Canine Parvovirus Genetic Variants |
| 04/16/2009 | US20090098123 Hcv coreceptor and methods of use thereof |
| 04/16/2009 | US20090098121 Monoclonal antibody fusion comprising bactericidal agent for use in targeted destruction of microorganisms; for use in health care, veterinary medicine and food processing |
| 04/16/2009 | US20090098089 Reovirus for the treatment of neoplasia |
| 04/15/2009 | EP2048232A1 Non-replicating paramyxoviridae virus vector |
| 04/15/2009 | EP2048159A1 T cell receptor display |
| 04/15/2009 | EP1497468B1 Cells for detection of influenza and parainfluenza viruses |
| 04/15/2009 | EP1383796B1 Neurovirulent strain of the west nile virus and applications thereof |
| 04/15/2009 | EP1212446B1 Viral replicons and viruses dependent on inducing agents |
| 04/15/2009 | CN101410519A Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 04/15/2009 | CN101407788A Method for promoting multiplication of rabies virus |
| 04/14/2009 | US7517976 proteins and/or polypeptides encoded by DNA isolated from rna viruses, used as vaccines, for detection and treatment of swine infected with PRRSV |
| 04/14/2009 | US7517973 Expression vector comprising nucleotide sequences coding astrocyte enhanced/suppressed gene sequences for use as tool in identifying modulators for treatment and prevention of viral-related nervous system disorders |
| 04/14/2009 | US7517683 Gene expression of alphavirus; nucleotide sequences; induce immunology response; aids vaccine |
| 04/14/2009 | US7517643 Compounds displayed on replicable genetic packages and methods of using same |
| 04/14/2009 | US7517531 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 |
| 04/14/2009 | US7517520 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use |
| 04/14/2009 | CA2321215C Hybrid adenovirus-aav virus and method of use thereof |
| 04/09/2009 | WO2009046138A1 Methods for drying bacteriophage and bacteriophage-containing compositions, the resulting dry compositions, and methods of use |
| 04/09/2009 | WO2009045581A2 Bacteriophage with enhanced lytic activity |
| 04/09/2009 | WO2009043960A1 Anti-tumour agents based on viral protein a238l |
| 04/09/2009 | WO2009008921A3 Influenza b viruses with reduced sensitivity to neuraminidase inhibitors |
| 04/09/2009 | US20090093041 Methods for drying bacteriophage and bacteriophage containing compositions, the resulting dry compositions, and methods of use |
| 04/09/2009 | US20090093040 producer cell which produces virions that contain the vector; comprises a minimal vector construct, a minimal packaging construct, and a minimal viral surface protein expression construct |
| 04/09/2009 | US20090092638 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| 04/09/2009 | US20090092634 Chicken Virus Vaccine and Diagnostic |
| 04/09/2009 | US20090092627 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 04/09/2009 | US20090092620 Flu virus hemagglutinin specific monoclonal antibodies |
| 04/09/2009 | US20090092594 Mammalian genes involved in viral infection and tumor suppression |